NewsRamp Science, Exploration and Discovery Podcast

Study finds stiffer colon tissue in young adults with colorectal cancer; Powermax Minerals discovers rare earth mineralization in British Columbia; Soligenix Inc. advances rare disease therapeutics with platform science.

LaFleur Minerals Inc. advances in Quebec Abitibi Gold Belt; VolitionRx Limited achieves 99% purity in liquid biopsy technology for cancer detection. Study reveals tailored prevention approaches for Type 2 diabetes and excess belly weight as a stronger predictor of heart failure risk than BMI.

A study on mirror-image amino acids shows promise in targeting cancer cells while sparing healthy tissues, potentially leading to more effective treatments with fewer side effects. Companies like CNS Pharmaceuticals Inc. are advancing innovative solutions for cancer therapy.

NeuroOne®'s OneRF® technology shows promise in reducing seizure burden for epilepsy patients. Golden Cariboo Resources Ltd. acquires claims and updates drilling progress at the Halo zone.

Canamera Energy Metals advances rare earth portfolio with high-grade results; LaFleur Minerals makes strides in gold mining; LIXTE Biotechnology and Liora Technologies collaborate to revolutionize cancer treatment.

A study by 38 researchers validates VectorCertain's thesis on AI agents' self-governance challenges, highlighting the need for their four-gate governance architecture in the thriving AI market.

Osullivision Books debuts sci-fi novel "Within the Moon: Book 1 - Salvation" by Daniel JP O'Sullivan. Meanwhile, Next Generation Trust Company discusses including aerospace and defense assets in a self-directed IRA, highlighting investment opportunities and the importance of understanding governmental regulations.

Canamera Energy Metals Corp. advances rare earth projects, LaFleur Minerals Inc. unveils positive gold project assessment, breakthrough in gut microbiota for immunotherapy, LIXTE Biotechnology expands cancer trial, RiskFootprint™ offers comprehensive flood risk assessment tool.

Tonix Pharmaceuticals launched TONMYA for fibromyalgia, with positive reception. Creative Biolabs advances mRNA therapeutics with innovative LPP technology for personalized therapies.

Oragenics Inc. initiates Phase IIa trial in Australia for ONP-002, a neurosteroid for brain injury treatment. Canamera Energy Metals Corp. progresses with rare earth exploration in Brazil for secure supply chains.

Powermax Minerals finds promising rare earth element samples in British Columbia, G Mining Ventures Corp. reports significant gold reserve increase, and GeoVax Labs introduces a new COVID-19 vaccine for immunocompromised patients. Stonegate Capital Partners covers NeOnc Technologies' developments in CNS oncology treatments.

Canamera Energy Metals Corp. reports positive assay results in Brazil, while LaFleur Minerals Inc. advances in gold exploration and production in Québec and eastern Canada. Common biological vulnerability found in pediatric brain tumors offers potential for targeted therapies.

GeoVax Labs explores vaccine procurement, BioCorRx strengthens substance abuse treatment portfolio, NeuroThera Labs patents weight loss therapy, and other biotech advancements and milestones are highlighted in the industry.

Oragenics Inc. has secured approval in Australia for Phase IIa trial of ONP-002 neurosteroid drug targeting concussion treatment, with first patient dosing expected by March and data by end of 2026. Company plans for further U.S. trials.

Tonix Pharmaceuticals presents TONMYA data for fibromyalgia, Soligenix's SGX945 receives UK designation, AirTrap introduces new spore trap sampling, and various companies announce advancements in healthcare and environmental sectors.

LIXTE Biotechnology targets tumor immunogenicity, Renewal Fuels expands with fusion research, and NRx Pharmaceuticals opens a new clinic for depression and PTSD treatment.

Omineca Mining partners with PSI Group to fund Fraser Canyon Project in exchange for 75% of recovered metals. High stress post-pregnancy linked to heart health risks, emphasizing the need for stress management in women with adverse pregnancy outcomes.

Recent poll shows high confidence in the American Heart Association as a reliable health information source. Soligenix utilizes platform science to enhance therapeutic reach in dermatology.

Fleetmikewood Protocol introduces Informational Engineering, transforming human genome into a Read/Write System for personalized health optimization and DNA evolution.

Renowned neurosurgeon Dr. Joseph C. Maroon joins Lionheart Health, enhancing their focus on bioelectric stimulation therapies to improve brain health and vitality.

The Functional Longevity Summit showcases advancements in precision medicine while a new MH370 search proposal suggests a targeted underwater search area based on NASA data.

Thailand introduces the RISE Fund to drive academic research towards tangible economic and social outcomes through strategic partnerships and innovation.

Lexaria Bioscience Corp. reveals its new R&D program for 2026, focusing on human and animal studies to enhance business opportunities through improved formulations and development opportunities.

Sino Biological introduces antigens for WHO-recommended 2026-2027 flu vaccine strains, including A (H3N2) subclade K and B/Victoria lineage, to support global vaccine research and advance influenza preparedness.

Trailbreaker Resources Ltd. increases its flow-through financing to $3.5 million, oversubscribed by $500,000, to fund critical mineral exploration expenses for its exploration projects.